Blueprint Medicines shares owned by Citadel Advisors
Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Blueprint Medicines
Tip: Access up to 7 years of quarterly data
All positions including Blueprint Medicines held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Blueprint Medicines by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $26M | 284k | 92.50 |
| 2024-06-30 | $31M | 287k | 107.78 |
| 2024-03-31 | $18M | 187k | 94.86 |
| 2023-12-31 | $24M | 261k | 92.24 |
| 2023-09-30 | $8.1M | 161k | 50.22 |
| 2023-06-30 | $10M | 159k | 63.20 |
| 2023-03-31 | $15M | 328k | 44.99 |
| 2022-12-31 | $12M | 284k | 43.81 |
| 2022-06-30 | $13M | 249k | 50.51 |
| 2022-03-31 | $29M | 455k | 63.88 |
| 2021-12-31 | $11M | 105k | 107.11 |
| 2021-09-30 | $1.2M | 12k | 102.71 |
| 2021-06-30 | $1.4M | 16k | 87.95 |
| 2021-03-31 | $1.8M | 18k | 97.25 |
| 2020-12-31 | $5.6M | 50k | 112.15 |
| 2020-09-30 | $9.6M | 103k | 93.19 |
| 2020-06-30 | $36M | 467k | 78.00 |
| 2020-03-31 | $29M | 497k | 58.48 |
| 2019-12-31 | $11M | 134k | 80.10 |
| 2019-09-30 | $18M | 238k | 73.47 |
| 2019-06-30 | $8.7M | 92k | 94.33 |
| 2019-03-31 | $9.1M | 114k | 80.05 |
| 2018-12-31 | $2.8M | 52k | 53.89 |
| 2018-09-30 | $21M | 268k | 78.07 |
| 2018-06-30 | $6.2M | 98k | 63.49 |
| 2018-03-31 | $5.0M | 55k | 91.67 |
| 2017-12-31 | $6.7M | 88k | 75.42 |
| 2017-09-30 | $3.1M | 45k | 69.66 |
| 2017-06-30 | $18M | 352k | 50.67 |
| 2017-03-31 | $7.6M | 190k | 39.99 |
| 2016-12-31 | $2.1M | 75k | 28.05 |
| 2016-09-30 | $554k | 19k | 29.71 |
| 2015-12-31 | $3.6M | 137k | 26.34 |
| 2015-09-30 | $11M | 547k | 20.83 |